NAD Augmentation to Prevent or Reverse Alzheimer's Disease in People With Down Syndrome
NAD Augmentation to Prevent or Reverse Alzheimer's Disease in People With Down Syndrome
Not yet recruiting · NCT07278492 · Registry updated 2026-08-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NAD Augmentation to Prevent or Reverse Alzheimer's Disease in People With Down Syndrome | Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Down syndrome, Neurobehavioral Manifestations, Neurologic Manifestations, chromosomal disorder, hereditary disease, intellectual disability, nervous system disorder | Not yet recruiting | Phase 1 | 2026-08-19 | NCT07278492 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Brigham and Women's Hospital | 378 |
| National Institutes of Health (NIH) | 667 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Brigham and Women's Hospital | Boston | United States | 511 |
| Massachusetts General Hospital | Boston | United States | 1015 |